Publications by authors named "Jean Lang"

Claim this Profile
I
Improvement of the Dengue Virus (DENV) Nonhuman Primate Model via a Reverse Translational Approach Based on Dengue Vaccine Clinical Efficacy Data against DENV-2 and -4.
Veronique Barban, Nathalie Mantel, Aymeric De Montfort, Anke Pagnon, Fabrine Pradezynski, Jean Lang

J Virol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination Against Dengue: Challenges and Current Developments.
Bruno Guy, Jean Lang, Melanie Saville, Nicholas Jackson

Annu Rev Med· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward.
Bruno Guy, Olivier Briand, Jean Lang, Melanie Saville, Nicholas Jackson

Vaccine· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico.
Gustavo H Dayan, Juan-Francisco Galán-Herrera, Remi Forrat, Betzana Zambrano, Alain Bouckenooghe, Jean Lang

Hum Vaccin Immunother· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virus.
Gustavo H Dayan, Konstantin Pugachev, Joan Bevilacqua, Jean Lang, Thomas P Monath

Viruses· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of Th1/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore.
Anke Harenberg, Sarah Begue, Audrey Mamessier, Sophie Gimenez-Fourage, Ching Ching Seah, Jean Lang

Hum Vaccin Immunother· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of tetravalent dengue vaccine in Thai schoolchildren - Authors' reply.
Arunee Sabchareon, Derek Wallace, Jean Lang, Alain Bouckenooghe, Annick Moureau

Lancet· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of chimeric yellow fever 17D/dengue viral replication in ticks.
Mária Kazimírová, Nathalie Mantel, Sandrine Raynaud, Mirko Slovák, Katarína Ustaniková, Jean Lang

Vector Borne Zoonotic Dis· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial.
Arunee Sabchareon, Derek Wallace, Chukiat Sirivichayakul, Kriengsak Limkittikul, Pornthep Chanthavanich, Jean Lang

Lancet· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Sanofi Pasteur tetravalent dengue vaccine.
Jean Lang

Rev Inst Med Trop Sao Paulo· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Q&A session 06 October 2011: I International Symposium on Dengue, FMUSP, São Paulo.
Jean Lang, Lucia F Bricks, Giovanini Coelho

Rev Inst Med Trop Sao Paulo· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broad neutralization of wild-type dengue virus isolates following immunization in monkeys with a tetravalent dengue vaccine based on chimeric yellow fever 17D/dengue viruses.
Veronique Barban, Jorge L Munoz-Jordan, Gilberto A Santiago, Nathalie Mantel, Yves Girerd, Jean Lang

Virology· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the potential of a candidate dengue vaccine with mathematical modeling.

PLoS Negl Trop Dis· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stability of yellow fever virus under recombinatory pressure as compared with chikungunya virus.
Charles E McGee, Konstantin A Tsetsarkin, Bruno Guy, Jean Lang, Kenneth Plante

PLoS One· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparing for introduction of a dengue vaccine: recommendations from the 1st Dengue v2V Asia-Pacific Meeting.
Sai Kit Lam, Donald Burke, Maria Rosario Capeding, Chee Keong Chong, Laurent Coudeville, Jean Lang

Vaccine· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Priming effect of dengue and yellow fever vaccination on the immunogenicity, infectivity, and safety of a tetravalent dengue vaccine in humans.
Ming Qiao, David Shaw, Remi Forrat, Anh Wartel-Tram, Jean Lang

Am J Trop Med Hyg· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine.
Bruno Guy, Beatrice Barrere, Claire Malinowski, Melanie Saville, Remy Teyssou, Jean Lang

Vaccine· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decay and persistence of maternal dengue antibodies among infants in Bangkok.
Willem G van Panhuis, Christine Luxemburger, Krisana Pengsaa, Kriengsak Limkittikul, Arunee Sabchareon, Jean Lang

Am J Trop Med Hyg· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines.
Rosario Z Capeding, Imelda A Luna, Emily Bomasang, Socorro Lupisan, Jean Lang

Vaccine· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Live-attenuated Tetravalent Dengue Vaccine in Dengue-naïve Children, Adolescents, and Adults in Mexico City: Randomized Controlled Phase 1 Trial of Safety and Immunogenicity.
Jorge Poo, Francisco Galan, Remi Forrat, Betzana Zambrano, Jean Lang

Pediatr Infect Dis J· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different innate signatures induced in human monocyte-derived dendritic cells by wild-type dengue 3 virus, attenuated but reactogenic dengue 3 vaccine virus, or attenuated nonreactogenic dengue 1-4 vaccine virus strains.
Claire Balas, Audrey Kennel, Florence Deauvieau, Regis Sodoyer, Nadege Arnaud-Barbe, Jean Lang

J Infect Dis· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dengue vaccine prospects: a step forward.
Bruno Guy, Jeffrey Almond, Jean Lang

Lancet· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Tetravalent dengue vaccine development].
Bruno Guy, Mélanie Saville, Jean Lang

Virologie (Montrouge)· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective cohort study of dengue infection in schoolchildren in Long Xuyen, Viet Nam.
Nguyen Thi Kim Tien, Christine Luxemburger, Nguyen Trong Toan, Laurence Pollissard-Gadroy, Vu Thi Que Huong, Jean Lang

Trans R Soc Trop Med Hyg· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Sanofi Pasteur tetravalent dengue vaccine.
Bruno Guy, Melanie Saville, Jean Lang

Hum Vaccin· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis